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Abstract
Background Perioperative intravenous (IV) infusion of
lidocaine has been shown to decrease post-operative pain,
shorten time to return of bowel function, and reduce the
length of hospital stay. This randomized, prospective,
double-blinded, placebo-controlled clinical trial evaluated
the impact of IV lidocaine on the quality of post-operative
analgesia and other outcomes after hand-assisted laparo-
scopic colon surgery.
Methods Sixty four patients with colon cancer scheduled
for elective colon resection were involved in this study.
Patients were randomized to receive either lidocaine infu-
sion [lidocaine group (LG)] or normal 0.9 % saline infu-
sion [placebo group (PG)] for a period of 24 h. Anaesthetic
and surgical techniques were standardized. Twenty-four-
hour post-operative analgesia in the recovery area was
maintained by continuous infusion of 0.1 lg/kg/h fentanyl.
The primary outcome of the study was post-operative pain
control. Pain was assessed using visual analogue scale
(VAS) scores at 2, 4, 8, 12, and 24 h after surgery. Patients
with a VAS score[3 were treated with ketorolac 30 mg as
needed. Secondary outcomes included time to resumption
of bowel function and length of hospital stay. Data in the
two groups were compared using the two-tailed Student’s
t test. All statistical tests were two-tailed at a significance
level of 0.05.
Results Demographic characteristics and clinical features
of both groups were similar. Intensity of pain at rest in LG
compared with PG was significantly lower during the first
24 h post-operatively. LG patients reported significantly
less pain during movements at 2-, 12-, and 24-h post-sur-
gery than PG patients. The study showed that ketorolac
consumption was significantly higher in PG: mean ketor-
olac consumption in LG was 43.77 ± 13.86 mg and in PG
51.67 ± 13.16 mg (p = 0.047). Compared with placebo,
lidocaine infusion produced a 32 % reduction in time to the
first drink (Cohen’s d = 3.85), 16 % reduction in time to
the first full diet (Cohen’s d = 3.35), and 18 % reduction
in time to the first bowel movement (Cohen’s d = 2.30).
Patients who received lidocaine stayed in hospital 1.2 days
less than patients who received placebo (p \ 0.01, Cohen’s
d = 0.72). There were no significant differences in sur-
gery-related complications between the two groups.
Conclusions Perioperative continuous IV lidocaine infu-
sion has a beneficial effect as regards post-operative pain,
restoration of bowel function, and length of hospital stay in
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patients who have undergone hand-assisted laparoscopic
colon surgery.
Keywords Acute pain  Analgesics  Post-operative 
Lidocaine  Laparoscopic  Hemicolectomy  Hand-assisted
laparoscopic colonic surgery (HALS)
Introduction
Clinical and scientific data show that laparoscopic methods
in colon surgery accelerate dietary intake and return of
bowel function, facilitate post-operative mobilization,
reduce the length of stay in hospital, and reduce the post-
operative mortality rate [1–6]. A number of meta-analyses
and systematic reviews proved the safety of hand-assisted
laparoscopic surgery (HALS) for patients with colon
malignancies [1–6].
Furthermore, post-operative pain management in the
treatment of acute pain after HALS (compared with con-
ventional surgery) improves both the success of the sur-
gical intervention and patient comfort [5–7]. To date no
standard method of post-operative analgesia for patients
undergoing HALS has been developed, and this has led to
the employment of various types of analgesia. These have
included epidural analgesia, patient-controlled analgesia,
intravenous (IV) agents, and spinal anaesthesia [8].
Recently, there has been a surge of interest in the use of IV
lidocaine in abdominal surgery due to its analgesic, antihy-
peralgesic, and anti-inflammatory effects. It has been shown
that perioperative administration of IV lidocaine decreases
post-operative pain, minimizes the use of opioids, facilitates
earlier restoration of bowel function, and shortens the length
of hospital stay after colon surgery [9, 10].
The aim of this study was to assess the effectiveness of
IV lidocaine versus placebo on the post-operative pain
level, requirements for analgesics, duration of post-opera-
tive ileus, and length of hospital stay in patients undergoing
hand-assisted laparoscopic colon surgery.
Materials and methods
This randomized prospective double-blinded placebo-con-
trolled single-centre trial was performed at the Institute of
Oncology, Vilnius University, Lithuania. The study was
approved by the Local Ethics Committee and written
informed consent was obtained from all patients.
Study population
Consecutive adult patients 18–75 years old with colon
cancer scheduled for an elective laparoscopic colon
resection under general anaesthesia were invited to par-
ticipate in this study. Patients were enroled from March
2010 until March 2012. Patients American Society of
Anaesthesiologists (ASA) score of I, III, or III, with normal
cognitive function and able to give informed consent, were
eligible for inclusion in the study. Patients with severe
hepatic, renal, cardiac, respiratory, and endocrine disease
and history of alcohol or drug addiction, those taking
analgesics pre-operatively and those with allergy to local
anaesthetic were excluded from the study.
The study hypothesis was that lidocaine infusion would
result in better pain relief, earlier resumption of bowel
function, and a shorter hospital stay in patients undergoing
hand-assisted laparoscopic colon surgery.
Anaesthesia technique and lidocaine administration
For all patients, anaesthetic management was standardized
and based on the standards of care adopted in our institu-
tion. General anaesthesia was provided to all patients using
fentanyl 1.5 lg/kg and propofol 2 mg/kg for induction, and
tracheal intubation was achieved with rocuronium. Intra-
operative muscle relaxation was monitored using a nerve
stimulator. Arterial blood pressure and heart rate were
maintained within 20 % of baseline values. Supplemental
doses of 50 lg of fentanyl were administered if intraop-
erative blood pressure or heart rate were 20 % higher than
baseline. Intraoperative blood pressure or heart rate 20 %
lower than baseline was treated with IV ephedrine.
Anaesthesia was maintained with sevoflurane in a mixture
of air 40 % and oxygen 60 %, and end-tidal concentration
of sevoflurane was adjusted to maintain the bispectral
index within range, between 40 and 60. Twenty-four-hour
post-operative analgesia in the recovery area was main-
tained by continuous infusion of 0.1 lg/kg/h fentanyl.
For LG patients, an IV bolus of lidocaine 1.5 mg/kg was
given (maximum 100 mg) just before the induction of
anaesthesia, followed by an IV infusion of lidocaine 2 mg/
kg/h during the entire surgical procedure. The dose of
lidocaine was then lowered to 1 mg/kg/h in the post-
operative anaesthesia care unit and continued for the first
24 h after surgery. PG patients received the same amount
of pre-operative bolus and continuous infusion of normal
saline during surgery and for 24 h after the operation.
Surgical technique
All hand-assisted laparoscopic colon operations were car-
ried out by the same team of surgeons experienced in this
procedure. With the patient under general anaesthesia, in a
supine horizontal position with legs stretched, body fixed to
the operating table and operator standing between the
stretched legs, a 6–6.5 cm transumbilical incision is
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performed. The assistant is standing on the right side of the
patient and the scrub nurse on the left side. The laparo-
scopic port is inserted and a left hand is introduced into the
abdomen. Under hand control, a 5-mm trocar is inserted in
the left lateral quadrant few centimetres above and towards
the midline from the anterior superior iliac spine, and a
10-mm trocar is inserted at the level of the right midcal-
vicular line few centimetres above the umbilicus (camera
port, to allow visualization of both the splenic flexure and
transverse colon, and the pelvic area). A 12-mm trocar is
inserted 2–3 cm towards the midline and 2–3 cm below the
right anterior superior iliac spine. Mobilization begins with
the descending colon moving upwards to splenic flexure
and left side of transverse colon, using a hand and a har-
monic scalpel (cranial part elevated and patient turned to
the right). After this part is finalized, the operator moves to
the right side of the patient (same as assistant surgeon) and
mobilization continues with the sigmoid colon, then lifting
the rectosigmoid colon at the level of the promontorium
with superior rectal vessels and continuing the mobilization
from the left side, using a 12-mm trocar for the harmonic
scalpel, visualizing the left ureter (caudal part elevated and
turned to the right). Then, the inferior mesenteric artery is
mobilized and ligated using titanium 10-mm clips 1–2 cm
from the aorta, and the inferior mesenteric vein is mobi-
lized and ligated with same clips at the level of the liga-
ment of Treitz. The specimen is divided at the level of the
promontorium, using an endoscopic linear stapler (60 mm).
The specimen is removed through the hand port incision,
and further anastomosis is fashioned laparoscopically using
a double-stapling technique. The water–air leak test is
performed and the doughnuts are examined to ensure
completeness. No drain is routinely used. The fascia is
closed at the level of the 12-mm trocar with a single
interrupted suture, and the hand port with a running po-
lydioxanone 0 suture. The skin incisions are closed with
interrupted sutures.
Randomization and blinding
Patients were allocated to LG or PG before surgery using a
computer-generated randomization list of random numbers.
An anaesthesia nurse not involved in the patients’ treat-
ment and evaluation drew lidocaine or normal saline into
two syringes labelled with each patient’s number and the
administration route: for bolus and for infusion. Patients
and those who gathered data (treating surgeons, anaesthe-
siologist, and nurse) were blinded to study allocation.
Outcome measures
The primary outcomes of the study were post-operative
pain control evaluated by determining the intensity of pain
and ketorolac consumption. The intensity of abdominal
pain at rest and during movement (i.e. deep breathing,
coughing) was assessed regularly at 2, 4, 8, 12, and 24 h
after the operation using visual analogue scale (VAS) pain
scores (from 0 to 10: 0 means no pain, whereas a score of
10 equals the worst pain ever experienced). Patients
received an information sheet and verbal training on
completing the pain scores. Patients with a VAS score [3
were treated with IV ketorolac 30 mg as needed. Ketorolac
consumption was registered.
Secondary outcomes included time to resumption of
bowel function and length of hospital stay. All patients
were instructed to report the time of the first flatus and
bowel movement. The patient informed the nursing staff,
who documented the time. Patients were discharged from
the hospital after pain control using oral pain medication
had been optimized, bowel function had resumed, and they
had started to tolerate a solid diet, had become mobile, and
were able to perform daily activities independently or with
minimal aid. There were no changes in trial outcomes after
the start of the study.
Data collected as well included surgery-related com-
plications (ileus, nausea and vomiting, urinary retention
requiring insertion of a urinary catheter, anastomotic leak,
and wound infection).
Statistical analysis
The primary outcome variable was the VAS pain score
after surgery. A previous study had been conducted where
VAS pain scores at rest and at movements were recorded 2,
4, 8, 12, and 24 h after hand-assisted laparoscopic colon
surgery for 15 patients who had received IV normal saline
[11]. The biggest standard deviation (SD) of the scores in
this group was 1.6. A similar SD was assumed for patients
receiving IV lidocaine. To estimate the group size needed
to show statistical significance, assuming a between-group
difference in VAS pain score of 1.3 as reported by Galla-
gher et al. [12] with a two-tailed a = 0.05 and power of
80 %, it was calculated that a minimum of 24 patients/
group was required. One of the secondary outcomes was
time to the first bowel movement. The average time to
return of bowel movements in the lidocaine subgroup of
the study of Groudine et al. [13] was 61.8 ± 13.2 h.
Sample size calculation confirmed that 24 patients in each
group were sufficient to demonstrate a difference in time to
return of the bowel movement with a two-tailed a = 0.05
and a power of 80 % [13]. The total number of patients was
increased to 64 to include dropouts.
Continuous data [age, weight, height, body mass index
(BMI), duration of surgery, duration of anaesthesia, pain
scores, ketorolac consumption, time to the first drink, time
to a full diet, time to the first bowel movement, and length
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of hospital stay] are presented as mean ± SD and 95 %
confidence interval (CI) and analyzed using Student’s t test
or the Mann–Whitney U test as appropriate. Data regarding
patient gender, ASA score, and number of patients with
surgery-related complications are presented as frequency
and percentage and analyzed with the v2 test or Fisher’s
exact test as appropriate. To evaluate the relative impact of
lidocaine infusion on pain control, ketorolac consumption,
and time to resumption of bowel function, we estimated the
effect size of each intervention through Cohen’s d test.
Ketorolac consumption effect on pain scores and time to
bowel functions restoration was assessed using a general
linear model.
All statistical tests were two-tailed at a significance level
of 0.05. Statistical analysis of data was performed using
SPSS version 18 for Windows (SPSS Inc., Chicago, IL,
USA).
Results
Sixty-four consecutive adult patients (61.7 % male and
38.2 % female) with a diagnosis of colon cancer were
recruited for the study. All patients underwent hand-assisted
laparoscopic hemicolectomy. Thirty-two patients were ran-
domized to receive lidocaine and 32 patients to receive
normal saline as placebo. Four patients had to be excluded
from final analysis because HALS was converted to lapa-
rotomy. The data of 60 patients were analyzed (Fig. 1). Mean
age was 56.6 ± 12.7 years, mean BMI 24.5 ± 2.4 kg/m2.
The lidocaine and placebo groups did not differ signif-
icantly with respect to age, gender, ASA score, height,
weight, BMI, duration of anaesthesia, or duration of sur-
gery (Table 1).
Intensity of pain at rest in LG compared with PG was
significantly lower during the first post-operative day at
each evaluation (p \ 0.01) (Fig. 2). Differences remained
significant after adjusting for ketorolac usage.
LG patients reported significantly less pain during
movements at 2-, 12-, and 24-h post-surgery than PG
patients (p \ 0.01) (Fig. 3). Difference remained signifi-
cant after adjusting for ketorolac usage. Lidocaine infusion
produced large effect on post-operative pain at rest and
during movements.
Twenty-seven (90.0 %) of PG patients required ketor-
olac and 22 (73.3 %) of LG patients required ketorolac
(p = 0.181). Patients receiving lidocaine consumed sig-
nificantly less ketorolac: mean ketorolac consumed by
patients receiving lidocaine was 43.77 ± 13.86 mg and PG
patients received on average 51.67 ± 13.16 mg of ketor-
olac (p = 0.047, Cohen’s d = 0.58).
Clinical data from the post-operative period are pre-
sented in Table 2. Mean time to the first drink, to the first
full diet, and to the first bowel movement was significantly
shorter in LG than in PG (10 and 6 h respectively,
p \ 0.01). Differences in time remained significant after
adjusting for ketorolac usage. Compared with placebo,
lidocaine infusion produced a 32 % reduction in time to the
first drink (Cohen’s d = 3.85), 16 % reduction in time to
the first full diet (Cohen’s d = 3.35), and 18 % reduction
in time to the first bowel movement (Cohen’s d = 2.30).
Patients who received lidocaine stayed in hospital
1.2 days less than patients who received placebo (p \ 0.01,
Cohen’s d = 0.72).
There were no complications directly related to anaes-
thesia observed in either group. Lidocaine-associated
hemodynamic changes such as severe hypotension, bra-
dycardia, and arrhythmia were not observed in any LG
patient during surgery. In addition, during the post-anaes-
thesia pot care unit stay, no patient complained of lido-
caine-induced toxicity such as light headedness, perioral
numbness, metallic taste, dizziness, and visual distur-
bances. There were no significant differences in surgery-
related complications (ileus or absence of bowel move-
ments, nausea, vomiting, urinary retention, anastomotic
leak, and wound infection) between the groups (Table 3).
Discussion
Despite a slow start, there has recently been a substantial
increase in the number of units performing laparoscopic
colorectal surgery for benign and malignant disease [14,
15]. Laparoscopic colon resection was introduced in 1991
[16, 17]. Large comparative studies and multiple prospec-
tive randomized control trials have reported equivalence in
resection margin, lymph node collection, tumour recur-
rence, post-operative complications, and long-term out-
comes between open and laparoscopic resection for colon
cancer [18, 19]. In addition, these studies demonstrated
earlier recovery of bowel function, less post-operative pain,
and decreased length of stay with the laparoscopic
approach which has heralded widespread acceptance for
laparoscopic resection of colon cancer [20, 21].
A standard method of post-operative analgesia for
patients undergoing laparoscopic colorectal surgery has not
yet been developed, and this has led to the employment of
various types of analgesia. These have included epidural,
intrathecal analgesia, patient-controlled analgesia, and IV
agents.
More recently, Kaba et al. [7] reported the use of IV
lidocaine for post-operative pain control. They found a
significantly shorter length of hospital stay, less time to
passing flatus and to the first bowel movement, and better
pain scores in patients who received IV lidocaine. The
doses that were used were equivalent to doses previously
376 Tech Coloproctol (2014) 18:373–380
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used for cardiac arrhythmias. These doses were adminis-
tered on the ward, post-operatively, with no complications.
Schlachta et al. [22] reported that use of IV ketorolac rather
than placebo significantly reduced the length of hospital
stay, as did the use of IV lidocaine compared to placebo.
The analgesic and anti-inflammatory effects of systemic
lidocaine administration may be a result of block or inhi-
bition of nerve conduction [13]. This is related to the
abilities of systemic lidocaine to depress spike activity,
amplitude, and conduction time in both myelinated A–C
and unmyelinated C fibres significantly [23]. In addition, it
has been shown that IV lidocaine decreased the heat-I
capsaicin-induced secondary hyperalgesia via its central
effect, which also suppressed secondary hyperalgesia in
experimental incision-induced pain by inhibiting central-
ization [24, 25].
Lidocaine toxicity follows a predictable progression and
can be divided into central nervous system and cardio-
vascular effects. At low plasma concentrations, these
include numbness of the tongue and perioral tissues. If
plasma concentrations reach higher levels, restlessness,
Randomized (n = 64)
Received intervention (n = 32) Received intervention (n = 32)
Analyzed (n = 30)
Allocated to placebo group (n = 32) Allocated to lidocaine group (n = 32)
Analyzed (n = 30)
Assessed for eligibility (n = 64)
Excluded (n = 0)
• Not meeting inclusion criteria (n = 0)
• Decline to participate (n = 0)
• Cancelled operation (n = 0)
Lost of follow up  (n = 0)
Converted to laparotomy (n = 2)
Lost of follow up  (n = 0)
Converted to laparotomy (n = 2)
Fig. 1 CONSORT diagram
showing progress of participants
through the study
Fig. 2 Comparison of mean visual analogue scale (VAS) scores in
lidocaine and placebo groups at rest
Table 1 Demographic characteristics and clinical data for lidocaine







Age (years) 57.20 ± 13.28 56.00 ± 12.22 0.717
Gender (male/female) 18/12 19/11 1.00
ASA score (I/II/III) 19/7/4 21/5/4 0.805
Height (cm) 174.97 ± 4.63 173.90 ± 4.96 0.393
Weight (kg) 73.00 ± 6.09 75.53 ± 5.69 0.101
BMI (kg/m2) 23.92 ± 2.62 25.01 ± 2.10 0.080
Duration of
anaesthesia (min)
115.00 ± 10.91 114.33 ± 10.96 0.814
Duration of surgery
(min)
113.67 ± 11.74 111.50 ± 10.68 0.458
ASA American Society of Anaesthesiologists, BMI body mass index,
SD standard deviation
Tech Coloproctol (2014) 18:373–380 377
123
vertigo, tinnitus, and accommodation disorder may be
apparent. Other adverse reactions caused by high concen-
trations may involve slurred speech, skeletal muscle
twitching, and drowsiness followed by seizures. Although
the side effects are dose-dependent, they are more frequent
at higher infusion rates (more than 3 mg/min). In this
study, lidocaine was infused at 1 mg/min for 24 h, and
there were no adverse reactions. Lidocaine toxicity tends to
occur at high plasma concentrations (more than 5 mkg/mL)
and has not been seen even when infused during longer
periods [26].
In previous studies [7, 9, 10, 13, 27, 28], it has been
suggested that lidocaine infusion (the doses and length of
treatment differ) is safe and causes no serious side effects.
However, perioral numbness and tinnitus were reported in
one study with IV lidocaine pain management [29].
Therefore, medical observation may be required as long as
the lidocaine infusion is continued.
The results of this study indicate that perioperative use
of IV lidocaine significantly reduces pain after surgery
compared with placebo in laparoscopic colorectal surgery.
Previous studies of visceral surgery [7, 9, 10, 13, 27, 28]
examined post-operative outcomes with systemic lidocaine
infusion from one to 24 h after intraoperative infusion.
Perioperative lidocaine infusion provided better pain relief
after radical prostatectomy [13], laparoscopic colectomy
[7], and colon surgery [28], whereas in a study by Koppert
et al. [9] and one by Herroeder et al. [10], lidocaine infu-
sion until 1 h after major abdominal surgery and until 4 h
after colorectal surgery, respectively, did not show a pre-
ventive effect on post-operative pain intensity. Neverthe-
less, lidocaine infusion of longer duration appears to
provide the most significant impact on post-operative
morbidity and length of hospital stay. In a study by Kaba
et al. [7], the authors suggested that the prolonged infusion
of lidocaine for 24 h following intraoperative infusion
resulted in significantly improved outcomes for all study
parameters such as pain scores, opioid consumption, sub-
jective feeling of fatigue, return of bowel function, and
length of hospital stay after laparoscopic colectomy.
Therefore, we suggest that the impact of perioperative
low-dose lidocaine infusion on length of hospital stay was
of a true benefit, consistent with previous results [7, 10,
13]. Earlier discharge of patients who received lidocaine
was suggested to be related to the rapid resolution of post-
operative ileus [7, 13]. Due to anti-inflammatory effects of
lidocaine, early recovery from ileus after surgery may be
attributed to the administration of lidocaine.
LG patients proved to have quicker recovery of bowel
function as evidenced by earlier time of first flatus as well
as first bowel movement. In our study, LG patients had a
bowel movement more than 24 h earlier than PG patients
and were discharged 1.2 days earlier.
Fig. 3 Comparison of mean visual analogue scale (VAS) scores in
lidocaine and placebo groups during movement
Table 2 Comparison of time to first drink, time to first full diet, first bowel movement, and length of hospital stay in lidocaine and placebo





Mean difference (95 % CI) p value
Time to first drink (h) 21.03 ± 2.41 31.03 ± 2.77 -10.00 (-11.34 to -8.66) \0.0001
Time to first full diet (h) 30.97 ± 1.83 36.97 ± 1.75 -6.00 (-6.93 to -5.08) \0.0001
First bowel movement (h) 26.97 ± 2.30 32.93 ± 2.86 -5.97 (-7.31 to -4.63) \0.0001
Length of hospital stay (days) 4.70 ± 1.29 5.90 ± 1.97 -1.2 (-2.06 to -0.34) 0.007
SD standard deviation
Table 3 Incidence of surgery-related complications in lidocaine and








Ileus, n (%) 3 (10.0 %) 5 (16.7 %) 0.706
Nausea, n (%) 5 (16.7 %) 6 (20.0 %) 1.000
Vomiting, n (%) 3 (10.0 %) 2 (6.7 %) 1.000
Urinary retention, n (%) 0 2 (6.7 %) 0.492
Anastomotic leak, n (%) 1 (3.3 %) 1 (3.3 %) 1.000
Wound infection, n (%) 0 1 (3.3 %) 1.000
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The findings of Wongyingsinn et al. [30] and Swenson
et al. [31] demonstrate that perioperative IV infusion of
lidocaine has the same impact on post-operative restoration
of bowel function as epidural analgesia, with an equal
incidence of complications and duration of hospital stay.
This suggests that systemic lidocaine administration may
be an appropriate alternative to epidural therapy, particu-
larly in settings in which epidural placement is technically
difficult, contraindicated, or undesired. This less invasive
approach to post-operative management would most likely
be simpler and potentially safer than epidural administra-
tion of local anaesthetic.
Post-operative nausea and vomiting are substantial
problems, since even mild nausea and vomiting can delay
discharge from hospital, leading to increased costs and
decreased patient satisfaction [31]. The present study
showed a benefit of IV lidocaine infusion in terms of
nausea, which might have been derived from of the anti-
inflammatory and propulsive effects of lidocaine. There
was, however, no statistically significant effect on nausea
or vomiting.
It remains unclear why patients undergoing abdominal
surgery may particularly benefit from IV lidocaine infu-
sion. One explanation might be the differences in pain
mechanisms; visceral pain from abdominal surgery might
be triggered by mechanisms other than those involved in
non-visceral pain. Part of the discomfort and pain follow-
ing abdominal surgery might be related to post-operative
ileus and nausea/vomiting. Indeed, the reduction observed
in the time to bowel function recovery as well as the
decreased incidence of nausea/vomiting might explain why
the improvement in pain control was observed mainly in
studies based on abdominal surgery.
There are some limitations associated with this study.
The present study analyzed pain scores and ketorolac usage
during the first 24 h after surgery at the same time patients
were receiving continuous infusion of 0.1 lg/kg/h fentanyl.
No data were collected on pain scores and analgesic usage
on the further days until discharge. Ketorolac usage by
patients in terms of pain scores and time was not analyzed.
Although our study showed advantages of IV lidocaine in
post-operative pain relief, we failed to show its superiority
compared with epidural anaesthesia. Also, our study did
not provide any data concerning cost-effectiveness. To
clarify both items, further studies are needed. Finally, out
prospective randomized trial was not registered with
ClinicalTrials.gov.
Conclusions
Continuous IV lidocaine infusion has a beneficial effect in
patients who have undergone HALS and decreases post-
operative pain, facilitating early restoration of bowel
function and shortening length of hospital stay.
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